Log in to save to my catalogue

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: syst...

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: syst...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1891859289

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

About this item

Full title

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

Publisher

Cambridge, UK: Cambridge University Press

Journal title

British journal of psychiatry, 2016-11, Vol.209 (5), p.385-392

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Although clozapine is the 'gold standard' for treatment-refractory schizophrenia, meta-analyses of clozapine for this condition are lacking.
We conducted a systematic review and meta-analysis of clozapine treatment for people with treatment-refractory schizophrenia.
We searched the Cochrane Schizophrenia Group's trial register, PubMed and EMB...

Alternative Titles

Full title

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1891859289

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1891859289

Other Identifiers

ISSN

0007-1250

E-ISSN

1472-1465

DOI

10.1192/bjp.bp.115.177261

How to access this item